94 results
Page 2 of 5
8-K
EX-10.1
iv69qy
3 May 19
ADMA Biologics Elects to Draw-Down $27.5 Million in Capital from Existing
5:00pm
8-K
EX-10.1
r4dlrf
12 Feb 19
Provides Funding to Support Ongoing Activities Including Inventory Ramp, Plant Expansion, Product Launch and Plasma Collection Center Development
7:47am
8-K
EX-10.2
hce4 wtqxogcr
12 Feb 19
Provides Funding to Support Ongoing Activities Including Inventory Ramp, Plant Expansion, Product Launch and Plasma Collection Center Development
7:47am
8-K
EX-10.1
6o46i vp7g
29 Jan 19
Departure of Directors or Certain Officers
5:15pm
8-K
EX-10.2
baylbjngx30u3
29 Jan 19
Departure of Directors or Certain Officers
5:15pm
8-K
EX-10.3
45xde2yggph0
29 Jan 19
Departure of Directors or Certain Officers
5:15pm
8-K
EX-10.1
tru9o
2 Jan 19
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.2
wntk46t20
24 Jul 18
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-10.1
wtq5pe uydtowc0ok5b
24 Jul 18
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-10.2
xy2co84rmm v1tihvad
11 Oct 17
Marathon Asset Management and ADMA Biologics Complete $30 Million Debt Refinancing
12:00am
8-K
EX-10.4
hjjw1zo 4c3ba
11 Oct 17
Marathon Asset Management and ADMA Biologics Complete $30 Million Debt Refinancing
12:00am
8-K
EX-10.3
3s73edwy efmxk
11 Oct 17
Marathon Asset Management and ADMA Biologics Complete $30 Million Debt Refinancing
12:00am
8-K
EX-10.1
xe13pz2 jm
11 Oct 17
Marathon Asset Management and ADMA Biologics Complete $30 Million Debt Refinancing
12:00am